UBS Group AG - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$1,465,000
+24316.7%
12,952
+22231.0%
0.00%
Q1 2017$6,000
-45.5%
58
-46.3%
0.00%
Q4 2016$11,000
-87.2%
108
-84.3%
0.00%
Q3 2016$86,0000.0%687
-15.6%
0.00%
Q2 2016$86,000
-91.2%
814
-90.5%
0.00%
-100.0%
Q1 2016$977,000
-93.7%
8,533
-92.2%
0.00%
-90.0%
Q4 2015$15,567,000
+70.3%
109,272
+7.3%
0.01%
+66.7%
Q3 2015$9,143,000
-22.1%
101,791
-0.1%
0.01%
-25.0%
Q2 2015$11,737,000
+21.0%
101,921
+0.3%
0.01%
+14.3%
Q1 2015$9,701,000
+42.9%
101,569
+0.6%
0.01%
+40.0%
Q4 2014$6,790,000101,0000.01%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Segantii Capital Management Ltd 50,000$5,288,0005.80%
RUDMAN ERROL M 37,001$3,934,0003.76%
INDUS CAPITAL PARTNERS, LLC 349,210$37,128,0003.60%
WARBURG PINCUS LLC 1,312,200$139,513,0003.04%
SPQ Asia Capital Ltd 96,000$10,206,0002.63%
OBERWEIS ASSET MANAGEMENT INC/ 82,775$8,801,0002.62%
Ativo Capital Management LLC 94,074$10,002,0002.44%
Sensato Investors LLC 99,764$10,607,0001.72%
Cormorant Asset Management, LP 112,867$12,000,0001.70%
BARING ASSET MANAGEMENT Ltd 131,284$13,958,0001.14%
View complete list of CHINA BIOLOGIC PRODS INC shareholders